Condition: Endometriosis · Chronic Pelvic Pain Syndrome · Sponsor: Reinier de Graaf Groep
The goal of this randomized controlled trial is to investigate the effect of esketamine versus placebo on the NRS score for chronic pelvic pain. Secondary endpoints are to assess pain scores, side-effects, quality of life, depressive symptoms and pain coping.
This description comes directly from the study's public registry record.
Mathijs Blikkendaal, MD, PhD · 070 340 1222 · M.Blikkendaal@rdgg.nl
Rozemarijn de Koning, MD · 070 340 1222 · Rozemarijn.deKoning@rdgg.nl
Always discuss trial participation with your own doctor first.
| Nederlandse Endometriose Kliniek, Reinier de Graaf Gasthuis | Delft, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06161805